Trial record 5 of 38 for: "Elephantiasis" | "Anthelmintics"
Effect of Albendazole Dose on Treatment of Lymphatic Filariasis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00511004|
Recruitment Status : Completed
First Posted : August 3, 2007
Results First Posted : August 31, 2015
Last Update Posted : August 31, 2015
National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute of Allergy and Infectious Diseases (NIAID) )
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
|Recruitment Details||Adults living in Kerala, India with Brugia malayi microfilaremia were recruited from field sites around the city of Alleppey and the study performed in the outpatient department of the TD Medical College.|
Study never fully enrolled so sample size was smaller than hoped for.